These analyses demonstrate that all six markers identify CAFs in breast cancer, and we therefore designed an antibody panel (see Table 3) consisting of the 5 cell surface CAF markers: FAPα, PDGFRα, PDGFRβ, PDPN and CD26. Here, PDGFRA is linked to breast cancer.